Kanadevia Corporation

7004.T
Pollution & Treatment Controls
2026/02/17 Updated
Market Cap: $1.2B (¥183.9B)
Stock Price: $7.12 (¥1,093)
Exchange Rate: 1 USD = ¥153.61

Notice Regarding Withdrawal from the Bridge Business and Cessation of Operations at the Mukojima Plant

Kanadevia Corporation will withdraw from the bridge business and plans to cease operations at the Mukojima Plant during fiscal year 2026. A special loss of approximately 1.6 billion yen is expected to be recorded in the third quarter of the fiscal year ending March 2026.

Importance:
Page Updated: February 5, 2026
IR Disclosure Date: February 5, 2026

Key Figures

  • Bridge Business Sales: 10,573 million yen (Consolidated sales ratio 1.7%, Fiscal year ending March 2025)
  • Number of Employees in Bridge Business: 239 (End of January 2026)
  • Number of Employees at Mukojima Plant: 157 (End of January 2026)
  • Special Loss: Approx. 1.6 billion yen (Scheduled to be recorded in Q3 of fiscal year ending March 2026)

AI要約

Background and Overview of Business Withdrawal

Kanadevia Corporation has decided to withdraw from the bridge business, which it has conducted for over 120 years, and to cease operations at the Mukojima Plant. The domestic new bridge construction market has been shrinking since peaking in fiscal year 1995, with the order volume declining significantly in recent years. Due to intensified competition and difficulty in securing stable orders, the company will discontinue plant operations and proceed with withdrawal as part of business structural reforms. The utilization of the former plant site has not been determined.

Future Schedule and Impact

From February 5, 2026, sales activities for new bridge business projects will be suspended, and the Mukojima Plant operations will be terminated during fiscal year 2026. Complete withdrawal from the bridge business is planned by fiscal year 2030. Consultations with the labor union are underway based on securing employment for employees. Additionally, due to the withdrawal, a special loss of approximately 1.6 billion yen in impairment loss will be recorded in the consolidated financial results for Q3 of the fiscal year ending March 2026.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.